Akero Therapeutics
AKRO
AKRO
181 hedge funds and large institutions have $2.9B invested in Akero Therapeutics in 2023 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 79 increasing their positions, 39 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.84% more ownership
Funds ownership: 101.88% → 102.72% (+0.84%)
7% less call options, than puts
Call options by funds: $140M | Put options by funds: $151M
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
Holders
181
Holding in Top 10
7
Calls
$140M
Puts
$151M
Top Buyers
| 1 | +$58.7M | |
| 2 | +$33.2M | |
| 3 | +$28.1M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$26.3M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$23.9M |
Top Sellers
| 1 | -$75.7M | |
| 2 | -$56.1M | |
| 3 | -$55.9M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$33.5M |
| 5 |
PA
Perceptive Advisors
New York
|
-$16.2M |